Little is known about the spliceosome's structure before its extensive remodeling into a catalytically active complex. Here, we report a 3D cryo-EM structure of a pre-catalytic human spliceosomal B complex. The U2 snRNP-containing head domain is connected to the B complex main body via three main bridges. U4/U6.U5 tri-snRNP proteins, which are located in the main body, undergo significant rearrangements during tri-snRNP integration into the B complex. These include formation of a partially closed Prp8 conformation that creates, together with Dim1, a 5 0 splice site (ss) binding pocket, displacement of Sad1, and rearrangement of Brr2 such that it contacts its U4/U6 substrate and is poised for the subsequent spliceosome activation step. The molecular organization of several B-specific proteins suggests that they are involved in negatively regulating Brr2, positioning the U6/5 0 ss helix, and stabilizing the B complex structure. Our results indicate significant differences between the early activation phase of human and yeast spliceosomes.
INTRODUCTION
The spliceosome forms stepwise on its pre-mRNA substrate by sequential recruitment of snRNPs (small nuclear ribonucleoproteins) and numerous other proteins (Papasaikas and Valcá rcel, 2016; Wahl et al., 2009) . During early spliceosome assembly, U1 and U2 snRNPs interact with the 5 0 splice site (ss) and branch site (BS), respectively, of the intron, forming the spliceosomal A complex. The pre-formed U4/U6.U5 tri-snRNP then joins the A complex, generating the pre-B complex in which the tri-snRNP is not yet stably bound (Boesler et al., 2016) . After conformational changes, including Prp28 RNA helicase-mediated exchange of U1 with U6 at the 5 0 ss, the pre-catalytic B complex with stably associated tri-snRNP is formed (Boesler et al., 2016; Staley and Guthrie, 1999) . Complex B undergoes extensive compositional and conformational rearrangements, including dissociation of U1 and U4, yielding the activated B act complex. The latter is converted into a catalytically active spliceosome (designated B*) that catalyzes step I of splicing, yielding the cleaved 5 0 exon and intron-3 0 exon lariat intermediates. At this stage, the spliceosomal C complex is generated and after additional rearrangements, the C* complex catalyzes step II, resulting in ligation of the 5 0 and 3 0 exons and release of the spliced-out intron.
During spliceosome assembly and activation a dynamic RNA-RNA network involving snRNAs and the pre-mRNA is formed (Staley and Guthrie, 1998) . U4 and U6 snRNA are extensively base paired in the tri-snRNP and B complex. During activation, the U4/U6 helices are unwound and a highly structured RNA network forms between the pre-mRNA and U2, U6, and U5 snRNAs, generating the spliceosome's catalytic RNA core Staley and Guthrie, 1998) . The U5 snRNP proteins Prp8 and RNA helicase Brr2 play central roles during catalytic activation. Prp8 is a major scaffolding protein that interacts with Brr2 and Snu114 (Wahl et al., 2009 ) and also forms a pocket that encompasses the catalytic RNA network of activated spliceosomes (Galej et al., 2014; Hang et al., 2015) . Brr2 initiates spliceosome activation by unwinding the U4/U6 snRNA helices (Laggerbauer et al., 1998; Raghunathan and Guthrie, 1998) . As Brr2 and its RNA substrate are present in the tri-snRNP and B complex, its activity must be regulated to ensure that U4/U6 unwinding first occurs during activation. In contrast to the situation in the S. cerevisiae tri-snRNP, Brr2 is located in human trisnRNPs at a large distance from the U4/U6 helices, thereby preventing their premature unwinding . Whether Brr2 is repositioned and engages its substrate in the human B complex, and if so, how Brr2 is negatively regulated at this stage of spliceosome assembly, is unclear.
Yeast and humans share a common set of core spliceosomal proteins that are evolutionarily conserved, but human spliceosomes contain many additional proteins not present in S. cerevisiae (Fabrizio et al., 2009) . For example, human B complexes contain a set of B-specific proteins, which include hSnu23, RED, Smu1, hMFAP1, FBP21, hPrp38, NPW38, and NPW38BP (Agafonov et al., 2011) . These proteins are conserved in higher eukaryotes, but only hSnu23, hPrp38, and hMFAP1 have homologs in S. cerevisiae (Agafonov et al., 2011; Ulrich and Wahl, 2017) . B-specific proteins first bind during B complex formation and are missing or much less abundant in B act complexes (Agafonov et al., 2011) . The function of most of these proteins remains unclear, but they are not required for tri-snRNP recruitment to the B complex (Boesler et al., 2016) . Instead, they likely contribute to the activation process, as indicated for Prp38 (Schü tze et al., 2016; Xie et al., 1998) , via currently unknown mechanisms. Several B-specific proteins are implicated in alternative splicing decisions, but the mechanisms whereby they achieve this is unclear (Papasaikas et al., 2015; Spartz et al., 2004) . 3D electron cryo-microscopy (cryo-EM) structures of the S. cerevisiae tri-snRNP, B act , C, and C* complexes and S. pombe post-splicing ILS spliceosomes Nguyen et al., 2016; Rauhut et al., 2016; Wan et al., 2016a Wan et al., , 2016b Yan et al., 2016 Yan et al., , 2017 Fica et al., 2017) , and of the human tri-snRNP and C* complex were recently reported Bertram et al., 2017; Zhang et al., 2017) . These studies revealed the spliceosome's molecular architecture during its activation and catalytic activity. However, relatively little information is available about the molecular organization of the spliceosome at early assembly stages before its activation. The structural organization of the human U4/U6.U5 tri-snRNP revealed by cryo-EM indicates that this major spliceosomal subunit is initially maintained in an inactive state. Thus major rearrangements in tri-snRNP components must occur to generate the functional centers required to prime the B complex for the subsequent activation step. To elucidate these structural changes, we determined the 3D cryo-EM structure of the human spliceosomal B complex at a core resolution of 4.5 Å and determined its spatial organization with the aid of protein crosslinking.
RESULTS AND DISCUSSION

Structure Determination and Model Building
By lowering the Mg 2+ concentration of the in vitro splicing reaction, we could affinity-purify human spliceosomes containing stoichiometric amounts of U2, U4, U5, and U6 snRNAs, but which were essentially devoid of U1 snRNA, indicating that they were stalled prior to Brr2-mediated activation and thus are spliceosomal B complexes ( Figure S1 ). Consistent with this, highly abundant proteins in these complexes included U2 and tri-snRNP proteins (except RBM42, Prp28, and Sad1, which were absent or present in low amounts), U2AF, B-specific proteins, and pre-mRNA binding proteins, such as the CBPs. Except for moderate amounts of Skip (hPrp45) and RBM22, Prp19 complex proteins, or other proteins typically present in activated spliceosomes were absent or present in very low amounts ( Figure S1D ). Chase experiments with micrococcal nuclease treated extract showed that our purified B complexes are functional ( Figure S1G ). However, incubation of the latter with ATP, did not induce significant displacement of U4 snRNP ( Figure S1F ), indicating that Brr2 is still inhibited at this stage. The 3D structure of the human B complex was determined by cryo-EM ( Figure S2 ), revealing a globular head domain and a triangular body with a central domain with adjacent ''foot, '' ''stump,'' and ''neck'' domains (Figure 1 ; Movie S1). Three major densities (B1-B3) bridge the head to the neck (B1) or stump (B2), or run as an extended density element almost parallel to the central axis of the main body (B3). Most of the triangular domain is well-defined and its structure was determined at an overall resolution of 4.5 Å (Figures 1 and S2) . However, the head and connecting bridges and some areas of the triangular body are more dynamic or contain components with substoichiometric occupancies and are thus less well resolved (Figures 1 and S2) . By fitting known X-ray structures or homology models of structured regions of B complex components into the EM density map (summarized in Table S1 ), and aided by chemical protein crosslinking coupled with mass spectrometry (Table S2) , we generated a pseudo-atomic model for the more stable parts of the B complex (Figure 1 ).
U2 snRNP Is Located in the B Complex Head Domain
Several U2-SF3a and SF3b proteins contact the pre-mRNA at or near the BS in A, B and B act complexes, stabilizing the U2/BS helix (Gozani et al., 1996) . In the S. cerevisiae B act complex the U2/BS helix is sequestered between the terminal HEAT repeats of the C-terminal HEAT domain of Hsh155 (SF3B1/SF3b155 in human) (Rauhut et al., 2016; Yan et al., 2016) . Consistent with earlier immuno-EM studies (Wolf et al., 2009) , we could fit the core of the SF3b complex together with the U2/BS helix, in a closed conformation as found in the B act complex (Rauhut et al., 2016; Yan et al., 2016) , into the B complex head domain (Figure 1 ). The SF3B3 WD40 domains are oriented toward the stump and the circular SF3B1 HEAT domain is oriented toward the neck of the body, while the U2 Sm core structure is located close to bridge B3 (Figure 1 ). One end of the U2/BS helix is located at the interface between the head and B3 (Figure 1 ). Based on protein crosslinks, U2 SF3a proteins are also likely located in this region, while the largely intrinsically unfolded C-terminal region of U2 SF3A1 appears to extend from the head through B3 into the lower part of the main body, where it is crosslinked to Prp8 and U5-40K ( Figure S1H ).
Organization of U4, U6, and U5 snRNA and the 5 0 ss Region of the Pre-mRNA We were able to trace most nucleotides (nts) of U4, U6, and U5 snRNA in the B complex body (Figure 1 ). The three-way helical junction of the U4/U6 snRNA is located in the upper part close to the neck. The U4 Sm and U6 LSm protein rings are located in the stump or at the B1 bridge between U2 snRNP and the neck, respectively. B1 contains, among others, U2/U6 helix II, in which the 5 0 end of U2 and 3 0 end of U6 are base paired (Figures 1B and 3C ). The major U5 stem-loop (SL) has a similar conformation in B and the tri-snRNP, with the U5 Sm core located in the foot of both ( Figure 1B ). However, in B, U5 loop 1 adopts a different conformation and loop 1 nucleotides U41 and U43 are base paired with 3 0 terminal nucleotides of the 5 0 exon, i.e., A-3 and G-1 ( Figures 1C and S3A ). An additional RNA helical element comprising the U6 ACAGA box base paired to several nucleotides near the 5 0 end of the intron is located ca 3-4 nm from the U5 loop 1/5 0 exon helix ( Figures 1B and 1C) , confirming that the U6 ACAGA/5 0 ss helix is formed in our B complexes. The 5 0 ss GU nucleotides at the intron's 5 0 end (G+1 and U+2) are positioned between both helical elements in an extended conformation with the two bases pointing away from each other ( Figure 1C ), which differs significantly from their conformation in the activated spliceosome ( Figure S3A ).
Interestingly, U6 nucleotides 30 to 40, immediately upstream of the ACAGA box, also form base pairs (including non-canonical ones) with additional intron nucleotides downstream of the 5 0 ss ( Figure 1C ). As an extended U6 ACAGA/5 0 ss helix is also present in the human C* complex (Bertram et al., 2017; Zhang et al., 2017) , but is not observed in yeast spliceosomes ( Figure S3B -3D), it may be a structural feature of the spliceosome solely in higher eukaryotes. Such extended helical elements may help to stabilize short RNA helices, such as the human U6 ACAGA . Blue, better-resolved densities. Gray, masked regions not seen in the 4.5 Å structure. B1, B2, B3, and density bridges connecting the head with the triangular body. (B) Location in the unmasked density of the U2 SF3b protein core and U2 Sm core in the head, and the U4 and U5 Sm cores, U6 LSm core, and major RNA elements in the main body. Inset, fit of the SF3B1 HEAT domain in complex with the U2/BS duplex. (C) Fit of the U5 SL, 3 0 end of the 5 0 exon, 5 0 ss nucleotides, and extended U6 ACAGA/5 0 ss helix into the 4.5 Å EM density map.
(D) Path of B3 (in the unmasked density) from the U2/BS helix to the end of the extended U6 ACAGA/5 0 ss helix. Stippled red line, possible path of the intron.
Distances between the branch adenosine and 5 0 ss, and between the U2/BS helix and extended U6/5 0 ss helix, are indicated.
See also Figures S1, S2, and S3, Tables S1 and S2 , and Movie S1.
box/5 0 ss helix. The extended bridge B3 (spanning ca 15 nm) connects the region where the U2/BS helix is located with the end of the extended U6 ACAGA/5 0 ss helix, suggesting B3 contains, in addition to protein, the middle part of the intron that connects these functionally important RNA helices ( Figure 1D ). The 5 0 ss and BS, which later must be juxtaposed for catalytic step 1 to occur, are physically separated by ca 16 nm in the B complex ( Figure 1D ). The 5 0 SL of U6 is located in a position similar to that observed in the yeast B act or human C* complexes, close to the U5 Sm core ( Figures 1B and S3 ). As the U6 5 0 SL and ACAGA box are likely located in the upper part of the isolated human tri-snRNP, they must be substantially repositioned upon tri-snRNP integration into the spliceosome.
Prp8 Adopts a Partially Closed Conformation and, Together with Dim1, Forms a 5 0 ss Binding Pocket The B complex central domain contains the U5 Prp8, Snu114, U5-40K and Dim1 proteins ( Figures 1A and S4A ). Whereas the positions and structures of the latter three, and of the Prp8 N-terminal domain 1 (NTD1), are very similar in the human tri-snRNP and B complex, the position of the Prp8 RT/En domain is clearly different. In the tri-snRNP, Prp8 has an open conformation, whereby the RT/En domain points upward and the tip of the En domain is separated from NTD1 by ca 5 nm (Figure 2A ). In the B complex, the RT/En domain has rotated by ca 20 around its long axis compared to its position in the tri-snRNP, and moved downward, such that several loops emanating from the RT/En linker are juxtaposed with Prp8 NTD1 and Dim1 (Figures 2B and S4) . While Prp8 adopts a partially closed conformation in the B complex, Prp8's active site pocket (formed by the RT/En, NTD1, and NTD2 domains), into which the catalytic U2/U6 RNA network docks during activation, is not completely closed, as found in catalytically activated spliceosomes ( Figure S4B ).
The partial rearrangement of Prp8 after tri-snRNP integration into the spliceosome, generates a protein pocket, comprised of residues of the Prp8 RT/En linker region, Prp8 NTD1 and Dim1, that binds the 5 0 ss GU dinucleotide in an extended conformation. That is, G+1 of the intron is sandwiched between loop regions (containing amino acids [aa] K1306 and F1551 to K1565, respectively) emanating from the Prp8 RT/En linker, while U+2 is contacted by a loop (aa 93-101) of Dim1, and by a helical region of Prp8 NTD1 (aa 532-537) ( Figures 2B to 2D ). Our structure thus suggests that the evolutionarily conserved Dim1 protein plays a direct, previously unknown role in 5 0 ss recognition in the B complex. Recognition of the extended 5 0 ss by an intricate network of RNA-RNA and RNA-protein interactions, as shown here, provides the structural basis for sequestering the 5 0 ss at this pre-catalytic stage of splicing.
The Prp8 RH domain is located above the RT/En linker, in both the B complex and human tri-snRNP, indicating that it has undergone a similar downward shift as the RT/En domain. However, the RH domain has rotated by ca 180 about its central axis in B and thus its spatial orientation differs dramatically between the two complexes (Figures 2A and 2B ). The 5 0 ss GU can be crosslinked to Prp8's RH domain at an early stage of spliceosome assembly (Reyes et al., 1999) . As the RH domain is separated from the 5 0 ss by ca 6 nm in our B complex (Figure 2B) , the proposed RH-5
0 ss interaction appears to take place at an earlier assembly step, presumably before disruption of the U1/5 0 ss interaction.
Brr2 Is Dramatically Rearranged and Binds to Its RNA Substrate in the B Complex
In human tri-snRNPs, Brr2 and the Prp8 Jab1 domain that tightly binds to it, are located close to the RT end of the Prp8 RT/En domain, and the active N-terminal helicase cassette (NC) of Brr2 is located ca 10 nm away from the U4/U6 duplex and the U4 Sm core structure ( Figures 2E and S4A ). In contrast, in the B complex, Brr2 is positioned near Prp8's En domain, ca 20 nm away from its position in the tri-snRNP, and the Prp8 Jab1 domain now contacts the tip of Prp8's En domain (Figures 2F and S4A) . This large-scale movement of Brr2 would require its rotation by ca 180 around the long axis of the tri-snRNP part of the B complex. Moreover, in the latter, the U4 Sm core is now located at the interface between Brr2's helicase cassettes, such that Brr2's NC is positioned between the U4 Sm core and U4/U6 helix I, which are connected via the central singlestranded region of U4 snRNA ( Figures 2F, 2G , and S1). This region of U4 is required for U4/U6 duplex unwinding by Brr2 in vitro, indicating that it functions as a docking site for Brr2's NC (Mozaffari-Jovin et al., 2012) . Consistent with this, the central single-stranded region of U4 runs across the two RecA domains of the NC, and RecA2 binds U4 nucleotides 69 to 73 downstream of U4/U6 helix I and is thus positioned close to helix I ( Figure 2G ). Thus in our B complex, Brr2 is bound to its RNA substrate and is poised to unwind the U4/U6 duplex and initiate the spliceosome activation process, but its helicase activity is still negatively regulated ( Figure S1F ). Interestingly, Brr2 does not appear to contact the double-stranded region of U4/U6 helix I ( Figure 2G ), which would be required for its ultimate unwinding. As described below, this contact is potentially prevented by the B-specific protein FBP21.
Remodeling of the U4/U6 Di-snRNP and Prp6 during B Complex Formation
The major domains of the U4/U6 proteins interacting with the U4/ U6 three-way junction are also located close to the B complex neck (Figure 3 ). Snu13, which directly interacts with the U4 k-turn motif, is located between the U4 5 0 SL and U4/U6 stem II, and also interacts with the C-terminal WD40 domain of Prp4 ( Figure 3B ). The Prp31 Nop domain interacts with Snu13 and the U4 k-turn motif in a manner similar to that observed in the co-crystal structure of Snu13, Prp31 and the U4 5 0 SL (Liu et al., 2007) . The Prp31 coiled-coil domain, however, has rotated ca 50
and is now closer to the Prp31 Nop domain in the B complex, and thus adopts a more compact structure ( Figure 3B , see also below). The C-terminal part of Prp31 has an extended conformation and runs between the phosphodiester backbone of the U4 5 0 SL and Dim1 ( Figure 3B ). Prp3 interacts closely with various parts of the U4/U6 duplex. Its C-terminal ferredoxin-like domain (FLD) binds to the 3 0 terminal single-stranded region of U6 (Liu et al., 2015) and likely stabilizes the neighboring U2/U6 helix II in bridge B1 ( Figure 3C ). Three a helices (H1-H3), located N-terminal to Prp3's FLD, interact directly with U4/U6 helices I (H1 and H2) and II (H3) (Figure 3D ). As both U4/U6 helices are subsequently unwound by Brr2, Prp3 may contribute to Brr2 regulation at this stage. Based on numerous protein-protein crosslinks, the N-terminal part of Prp3 runs across the Prp4 WD40 domain, and then passes along bridge B1, where it crosslinks with several proteins of the U6 LSm core and finally contacts the U2 SF3A1 and SF3B1 proteins in the head ( Figure S5A ). Thus, Prp3 may also play an important role in stabilizing this major connection between U2 and the trisnRNP during early spliceosome assembly. Prp4 bridges several U4/U6 proteins with each other. For example, its C-terminal WD40 domain interacts with Snu13, Prp3's FLD and Prp6, while its N-terminal-most helical bundle (NHB) bridges cyclophilin H (CypH) to a helix H1 of Prp3 ( Figures 3B and 3D ). Moreover, the N-terminal region of Prp4 additionally interacts with U2 SF3A proteins and Brr2's helicase domain, as indicated by multiple crosslinks ( Figure S5B ).
A comparison of the cryo-EM structures of the isolated trisnRNP and B complex reveals that in addition to Prp8 and Brr2, several U4/U6 components and Prp6 also undergo significant rearrangements upon/after tri-snRNP integration into the spliceosome. For example, in the B complex, the U4 Sm and U6 LSm core structures have undergone large-scale translocations (Figures 2E, 2F, 4A, and 4B) . Moreover, the entire complex of U4/U6 proteins, which includes Snu13, Prp4's WD40, Prp31's Nop, and Prp3's FLD domains, and the C-terminal TPR repeat domain of Prp6, has rotated counter-clockwise by ca 20-30 with respect to the Prp8 RT domain. Thus they, together with the U4/U6 three-way junction, are shifted closer to the Prp8 RT/En domain in the B complex ( Figure 4B ). The Prp6 C-terminal TPRs interact with Prp4, Snu13 and Prp3 in a very similar manner in both complexes, but they additionally contact Prp31's rearranged coiled-coil domain only in B ( Figure 3E , and see below). After tri-snRNP integration into the spliceosome, a major rearrangement also occurs within the N-terminal-most TPR repeats of Prp6, which are more extended in the B complex and whose interaction with Prp8's RT/En and RH domains has changed substantially ( Figures 4A and 4B ). The rearranged Prp6-Prp8 interaction appears to be stabilized in the B complex by a-helical regions of Snu66, which form a bridge stretching from Prp6's N-terminal TPRs to the Prp8 RT/En linker region, close to the switch loop ( Figure 4D ). The remaining part of Snu66, which is thought to be largely intrinsically unfolded, appears to be located close to Brr2's NC and CC, Prp8's linker, En, RH, and Jab1 domains, and Smu1, as indicated by protein-protein crosslinks (Tables S1 and S2 ).
Location and Potential Functions of the B-Specific Proteins
A number of B-specific proteins, whose domain organization is shown in Figure 5A , could be located in the B complex EM density map ( Figure 5B ), providing first insights into their potential functions. The B-specific protein Smu1 possesses an N-terminal, ca 180-aa-long, structured helical region (NTR), that contains LisH and CTLH domains, which is connected via a short linker region to a C-terminal WD40 domain (Ulrich et al., 2016a) . In the B complex, Smu1's C-terminal WD40 domain is located at the interface between Brr2's CC and the WD40 domain 2 of SF3B3. Moreover, based on crosslinks, we could place Smu1's NTR in a density element that bridges the WD40 domains of Smu1 and SF3B3 ( Figure 5C ). Thus, Smu1 and SF3B3's WD40 domains are the major constituents of the B2 bridge, and Smu1 may help to stabilize the position of Brr2 after its rearrangement. Smu1's WD40 domain is positioned at the interface of Brr2's NC and CC ( Figure 5D ), and thus might influence the relative orientation of both helicase cassettes and thereby potentially modulate the helicase activity of the NC (Santos et al., 2012) . The strategically important position of Smu1 in the B complex could explain why its mutation or deletion has profound effects on pre-mRNA splicing (Papasaikas et al., 2015; Spartz et al., 2004) .
Smu1 forms a heterodimer with the B-specific RED protein, stably binding a short region of the latter (i.e., aa 209-222) via its NTR (Ulrich et al., 2016a) . RED is largely intrinsically unfolded and we could not locate its precise position in the B complex EM density map. However, in our purified B complex, crosslinks were detected between the Smu1 NTR and the short region of (E) Fit of Prp6's C-terminal TPR repeats into the 4.5 Å EM density of the B complex and their interactions with the major domains of U4/U6 proteins. See also Figure S5 and Tables S1 and S2.
RED that binds to it, and between the latter and Prp8's RH domain. Moreover, we observed numerous crosslinks between the N-terminal part of RED and several U2 proteins in the head, while its C-terminal region was crosslinked to the Prp8 RT/En domain and NTD1 ( Figure S6A ). Thus, like Smu1, RED appears to play a role in bridging U2 with U5 proteins in the B complex. Several B-specific proteins contact the U6/5 0 ss helix and may aid in its repositioning within the spliceosome. The N-terminal domain (NTD) of Prp38 interacts simultaneously with several B complex proteins, and was crystallized in complex with short helices of MFAP1 and Snu23 (Ulrich et al., 2016b) . The Prp38 NTD is located close to the U6/5 0 ss helix, and appears to interact with the U6 ACAGA sequence (Figures 5B and 5E ). The a helices of Snu23 and MFAP1 that bind Prp38 fit into neighboring EM densities, and the N-terminal Snu23 zinc finger (ZnF) also interacts with the upper part of the extended U6 ACAGA/5 0 ss helix (Figures 5E and 5F). Prp38 is required to convert B into a B act complex (Schü tze et al., 2016; Xie et al., 1998) , but little is known about the molecular mechanism whereby it contributes to the activation process. A comparison of the position of the U6 ACAGA/5 0 ss helix in B and B act complexes indicates that it must be repositioned during activation to ultimately juxtapose the 5 0 ss and U2/U6 catalytic center ( Figure S3 ). As Prp38 and Snu23 contact the U6 ACAGA/5 0 ss helix, they may facilitate the repositioning of the latter during activation. In addition, or alternatively, they may help recruit proteins such as Cwc24 to the 5 0 ss during activation (Yan et al., 2016 ). MFAP1 appears to play a role in connecting the head and main body of the B complex, as indicated by protein crosslinks ( Figure S6B ).
Finally, in addition to Smu1, the B-specific protein FBP21 also contacts Brr2 and thus potentially aids in maintaining Brr2 in an inactive state in the B complex. The N-terminal region of FBP21 contains tandem WW domains (Huang et al., 2009) , and is predicted to contain at its very N terminus a ZnF that appears to be followed by a long a-helical element (Table S1 ). In the B complex, FBP21's N-terminal region indeed adopts a matrin-like ZnF structure that binds across the minor groove of the U6 ACAGA/ 5 0 ss helix ( Figure 5F ). The adjacent a helix fits into a density element that runs from the U6/5 0 ss helix toward the RecA2 domain of Brr2's NC and the CypH protein ( Figures 3D and  5E ). CypH interacts with Prp4, which in turn communicates via Prp3 with U4/U6 helix I ( Figure 3D ). The position of FBP21's N-terminal a helix between Brr2's NC (bound just upstream of U4/U6 helix I) and CypH, which indirectly binds U4/U6 helix I via Prp4 and then Prp3, suggests that it may act to maintain U4/U6 helix I and its associated proteins at a sufficient distance from Brr2's NC (i.e., hold it at bay), thereby preventing Brr2 contact with the double-stranded region of its substrate and potentially maintaining it in an inactive state. Our crosslinking results also suggest that the C-terminal region of FBP21 contacts Brr2's helicase domains and Prp4 ( Figure S6C ). Thus, a complex interaction network involving FBP21, Brr2, and the U4/U6 snRNP proteins potentially enables the tight regulation of Brr2 helicase activity at this stage. Release of FBP21 during the B to B act transition could play a key role in triggering Brr2 activity during spliceosome activation. Consistent with this idea, FBP21 is the only B-specific protein lost from spliceosomes that are blocked at an Tables S1 and S2. early stage of the B to B act transition, but in which the U4/U6 duplex has been unwound (Sidarovich et al., 2017) .
Tri-snRNP Rearrangements during Spliceosome Assembly Likely Involve Coordinated Remodeling Events
Comparison of the 3D structures of the B complex and human U4/U6.U5 tri-snRNP reveals that most tri-snRNP proteins undergo extensive repositioning and/or structural rearrangements during B complex formation ( Figure 6G ). These rearrangements likely occur in a highly coordinated and ordered manner, as the interaction sites of several components in the tri-snRNP and B complex are mutually exclusive. An intriguing question is how these coordinated remodeling events are triggered. Initial docking of the tri-snRNP to the A complex first generates a 37S pre-B complex. In the latter, U1 snRNA is still base paired to the 5 0 ss, and U2/U6 helix II has formed, but the tri-snRNP is not yet stably bound (Boesler et al., 2016) (Figures 6G and S1 ). Displacement of U1 from the 5 0 ss and establishment of the U6 ACAGA/5 0 ss interaction, which is mediated by the helicase Prp28, leads to a substantial structural change that converts the 37S pre-B complex into a 50S B complex with stably associated tri-snRNP (Boesler et al., 2015 (Boesler et al., , 2016 . Thus many of the rearrangements in tri-snRNP proteins described here likely occur during the pre-B to B transition, and formation of the U6 ACAGA/5 0 ss helix likely plays a key role in tri-snRNP remodeling. This suggests that Prp28 action may trigger or contribute to tri-snRNP rearrangements, and would likely create new conformational space and enable sampling of different RNP conformations within the spliceosome. The handover of U1 for U6 at the 5 0 ss likely influences the movement of the RT/En domain toward the Prp8 NTD1. In human tri-snRNPs, Prp28 is located between Prp8's RT/En and NTD1 ( Figure 6A ). The position of Prp28 in the tri-snRNP, and both the partially closed conformation of Prp8 and the formation/position of the U6 ACAGA/5 0 ss helix in the B complex, are mutually exclusive ( Figures 6A and 6B ). Prp28-mediated rearrangements must thus be coordinated with Prp28 displacement from the spliceosome. Interestingly, displacement of Prp28 is likewise a prerequisite for subsequent binding of the Prp38/Snu23/MFAP1 protein complex, whose binding site close to the U6/5 0 ss helix is also mutually exclusive with that of Prp28 ( Figures 5B, 6A, and 6B ). See also Figure S6 and Tables S1 and S2.
The Sad1 protein likely also plays a key role in triggering trisnRNP rearrangements. In the tri-snRNP ( Figure 6A ), Sad1 contacts the Prp31 coiled-coil domain and the Prp8 NTD2 and RT domains, as well as Snu114 and the Brr2 N-terminal PWI domain, which in turn is associated with Brr2's CC cassette . This suggests that Sad1 not only plays a role in stabilizing the interaction of the U4/U6 and U5 snRNPs, but that it may also help to tether Brr2 in a pre-activation position, i.e., away from the U4/U6 duplex. Strikingly, in the B complex cryo-EM structure we cannot localize any density accommodating Sad1, consistent with its underrepresentation in our B complex preparation. Thus Sad1 is clearly displaced from its original position in the tri-snRNP, which would allow most of the rearrangements in tri-snRNP proteins observed upon B complex formation. For example, in the B complex, the Prp31 coiled-coil domain is rearranged and is now juxtaposed with Prp31's Nop domain, whereas the a helices at the coiled-coil tip now directly interact with the Prp8 RT domain (Figures 6C and 6D ). This creates new binding sites for Prp6's C-terminal TPRs on Prp31, which would then facilitate the observed shift of the U4/U6 Tables S1 and S2. protein complex with respect to the Prp8 RT domain ( Figures 6E  and 6F ). Moreover, Sad1 displacement and the major rearrangements occurring within Prp6's N-terminal most TPRs (Figure 4 ) also disrupt interactions of these proteins with Brr2, which would allow the large-scale movement of Brr2 to its RNA substrate. Indeed, Prp6's position in the B complex and the position of Brr2's helicase domain, as found in the tri-snRNP, would be mutually exclusive in complex B ( Figure 4C ). As Sad1 is highly abundant in the human pre-B complex (Boesler et al., 2016) , its displacement likely occurs during the pre-B to B transition, which is consistent with the idea that most tri-snRNP rearrangements occur after its initial docking with the A complex. These trisnRNP structural changes would thus appear to be only possible within the context of the spliceosome where the interaction of U6 with the 5 0 ss is first possible. Prp4 kinase, which is required for human B complex formation, phosphorylates Prp6 and Prp31 (and possibly additional proteins) specifically during B complex formation (Boesler et al., 2016; Schneider et al., 2010) . Thus, phosphorylation of Prp31 and Prp6 could also potentially play an important role in tri-snRNP remodeling, by triggering conformational changes (e.g., in the Prp31 coiled-coil domain) and/or by stabilizing newly generated protein-protein and protein-RNA interactions.
Differences in the Activation Pathways of Human and S. cerevisiae Spliceosomes
A comparison of the cryo-EM structures of human and yeast U4/U6.U5 tri-snRNPs surprisingly revealed extensive differences, foremost in the position of Brr2 relative to its substrate, which already interacts with the U4/U6 duplex in the yeast trisnRNP Nguyen et al., 2015 Nguyen et al., , 2016 Wan et al., 2016b) . While our B complex structure shows that in humans the large-scale rearrangements that lead to loading of Brr2 onto its RNA substrate occur first during B complex formation, cryo-EM structures of purified S. cerevisiae tri-snRNPs suggest that these rearrangements already occur in isolated yeast tri-snRNPs. This suggests that either there is a fundamental difference in the structural organization of the yeast and human tri-snRNP, which is unlikely given the high conservation of their protein components, or that the human and yeast tri-snRNP structures represent different conformational states. Intriguingly, the structural organization of Prp8, Brr2, Prp6, and the U4/U6 proteins is highly similar in the yeast tri-snRNP and human B complex (Figures 7 and S7 ). This suggests that yeast trisnRNPs analyzed by cryo-EM potentially could be derived from endogenous B complexes and thus represent a spliceosome dissociation product. Consistent with this, one of the yeast tri-snRNP preparations analyzed by cryo-EM was reported to contain not only pre-mRNA but also U2 proteins (Wan et al., 2016b) . Furthermore, purified yeast tri-snRNPs appear to be activated pre-maturely, as they dissociate in the presence of ATP in a Brr2-dependent manner into U5, U4, and U6 snRNPs (Nguyen et al., 2015 (Nguyen et al., , 2016 Wan et al., 2016b) , while purified human tri-snRNPs and B complexes remain stable (Figure S1F ).
Alternatively, in yeast the tri-snRNP may readily be rearranged prior to its docking with the spliceosomal A complex, and thus not require additional protein or RNA contacts to trigger a (Nguyen et al., 2016 ) (B), and human tri-snRNP (C), as revealed by cryo-EM. All complexes are aligned relative to Snu114 and Prp8 NTD1, whose structures are very similar in all of the cryo-EM models. Similar results were obtained with the S. cerevisiae tri-snRNP cryo-EM structure from Wan et al. (2016b) . The organization of the tri-snRNP proteins is highly similar in the yeast tri-snRNP and recently published yeast B complex (Plaschka et al., 2017) . See also Figure S7 and Tables S1 and S2. structural rearrangement. Consistent with this, Sad1 is no longer present in the purified yeast tri-snRNP, which could potentially shift the equilibrium between different conformational states toward the B complex structural organization (Huang et al., 2014) . This would imply that the tri-snRNP rearrangement that leads to the loading of Brr2 onto its U4/U6 RNA substrate is more highly regulated in higher eukaryotes. Consistent with this idea, Prp4 kinase, which is essential for B complex formation in higher eukaryotes, is absent from S. cerevisiae.
Our results indicate that there are significant differences between the activation pathways of human and yeast spliceosomes. The presence of a number of additional proteins in the human B complex, which have no counterparts in S. cerevisiae and appear to function first during activation, is a first indication that the transformation of B into an activated B act complex is likely to be more complex in higher eukaryotes. Our cryo-EM structure of the human B complex further reveals that at least two of these proteins, namely, FBP21 and Smu1, contact Brr2 and potentially play important roles in regulating its helicase activity. Thus, the initial steps toward the formation of an activated spliceosome, namely, triggering U4/U6 duplex unwinding, appear to be different in the S. cerevisiae versus human spliceosome. After submitting this paper, a cryo-EM structure of the S. cerevisiae spliceosomal B complex was reported (Plaschka et al., 2017) . A comparison of the molecular architecture of the human and yeast B complexes, reveals that the structure and organization of most proteins common to the yeast and human B complexes are conserved. The location of most human B complex proteins in our model that have homologs in S. cerevisiae, for which only short pieces of structural information were available, e.g., MFAP1 (Spp381 in S. cerevisiae) or whose position was supported mainly by protein-protein crosslinking, is consistent with the position of their homologs in the yeast B complex structure. A notable difference between the yeast and human B complex structures is the lack of a U6 ACAGA/5 0 ss interaction in the yeast B complex despite that U1 snRNP is largely absent, which may indicate that the yeast complex is stalled at an earlier stage, but after release of U1.
Conclusions
Our cryo-EM structure of the human B complex provides important insights into the organization of the spliceosome prior to its activation. The B complex possesses a U2-containing head domain attached via three main bridges (B1-B3) to the main body where the U4/U6.U6 tri-snRNP and B-specific proteins are located. B1, which contains U2/U6 helix II, is likely involved in the initial docking of the tri-snRNP to the spliceosomal A complex. B2 may be important for stabilizing the association of the tri-snRNP within the B complex, whereas B3 allows communication between the U2/BS helix in the head and the extended U6 ACAGA/5 0 ss helix in the main body of the B complex. One of the most striking observations in this work is how tri-snRNP integration into the B complex leads to extensive rearrangements and/or repositioning of the majority of its proteins. These rearrangements lead, among others, to a partially closed conformation of Prp8 such that its RT/En and NTD1 domains, together with Dim1, form a protein pocket that binds the 5 0 ss. This is likely followed by the movement of the U4/U6 snRNP and Brr2 helicase, such that the latter now contacts its U4/U6 substrate and is poised for the subsequent spliceosome activation step. Thus, these rearrangements generate the functional centers required to prime the B complex for the subsequent activation step. In addition, they create binding sites for the B-specific proteins, ensuring that they are first recruited at this specific stage of spliceosome assembly. Our structure also reveals how several of the human B-specific proteins are organized in the B complex, and suggests they are involved in negatively regulating Brr2, positioning the U6/5 0 ss helix and/or stabilizing the B complex structure. Finally, our work solidifies the intriguing idea that there is a significant difference between the early events of the activation pathways of human and yeast spliceosome. Consistent with the large exchange of spliceosomal proteins and major rearrangements in the RNA network that occur during the B to B act transition, the general architecture of the B and B act complex are dramatically different (Fabrizio et al., 2009 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
For in vitro splicing and purification of spliceosomes, nuclear extract from HeLa S3 cells was used. HeLa cells were grown in DMEM/ F12 (1:1) medium supplemented with 5% NCS serum in a 30l fermenter (Applikon Biotek) at a density of 6.5 3 10 6 cells/ml and harvested using a Sorvall BIOS 16 centrifuge.
MBP-MS2 fusion protein was expressed in the Escherichia coli strain Rosetta 2 (DE3) (Novagen) which was grown in 2YT medium at 37 C.
METHOD DETAILS
In vitro splicing Uniformly [ 32 P]-labeled, m 7 G(5 0 )ppp(5 0 )G-capped MINX pre-mRNA was synthesized in vitro by T7 runoff transcription. HeLa S3 cells were obtained from GBF, Braunschweig (currently Helmholtz Zentrum fü r Infektionsforschung, Braunschweig) and tested negative for mycoplasma.
To prepare splicing active nuclear extracts, HeLa cells were grown to a density of 6.5 3 10 6 cells/ml and harvested by centrifuging for 10 min at 2000 rpm in a 8 3 2000 mL BIOS rotor (Thermo Scientific). Cells were washed twice with ice cold PBS (pH 7.4) and resuspended in 1.25 volumes of MC buffer [10 mM HEPES-KOH, pH 7.6, 10 mM KOAc, 0.5 mM Mg(OAc) 2 , 0.5 mM DTT] supplemented with 2 protease inhibitor cocktail tablets (Roche) per 50 mL of the buffer. They were then incubated for 5 min on ice and lysed with 18 strokes of a Dounce homogenizer at 4 C. Nuclei were pelleted for 5 min at 10000 rpm in a F14-14x50cy rotor (Thermo Scientific). After removing the supernatant, 1.3 volumes of Roeder C buffer [25% (v/v) glycerol, 20 mM HEPES-KOH, pH 7.6, 0.2 mM EDTA pH 8.0, 420 mM NaCl] supplemented with 0.5 mM DTT and 0.5 mM PMSF were added per gram of nuclei. The latter were then lysed with 20 strokes of a Dounce homogenizer. The mixture was stirred slowly for 40 min at 4 C, followed by centrifugation for 30 min at 12300 rpm in a F14-14x50 rotor (Thermo Scientific). The supernatant was recovered and was immediately used for B complex assembly as described below without dialysis or freezing.
To isolate B complexes, splicing was performed with 5 nM of 32 P-labeled pre-mRNA and 20% (v/v) HeLa nuclear extract, in buffer containing 0.3 mM MgCl 2 , 0.2 mM EDTA, 50 mM NaCl, 20 mM HEPES-KOH pH 7.9, 2 mM ATP and 20 mM creatine phosphate, and was incubated at 30 C for 2 hr.
MS2 affinity selection of splicing complexes Spliceosomal complexes were isolated by MS2 affinity selection. MINX pre-mRNA containing three MS2 aptamers at its 3 0 end RNA was incubated with a tenfold molar excess of MBP-MS2 fusion protein and then added to a splicing reaction. After incubating at 30 C for 2 h, centrifuging to remove aggregates, and adding 100 mM NaCl, the reaction was loaded onto a MBP Trap HP column (GE Healthcare). The column was washed with G-150 buffer (20 mM HEPES-KOH pH 7.9, 1.5 mM MgCl 2 , 150 mM NaCl) and complexes were eluted with G-150 buffer containing 1 mM maltose. Eluted complexes were loaded onto a 36 ml linear 5%-20% (w/v) sucrose gradient containing G-150 buffer, centrifuged at 25,000 rpm for 10 h at 4 C in a Surespin 630 (Thermo Scientific) rotor, and gradient fractions were harvested from the bottom. The distribution of 32 P-labeled MINX pre-mRNA across the gradient was determined by Cherenkov counting. Fractions were analyzed by denaturing 4%-12% NuPAGE (Life Technologies) followed by autoradiography and SYBR Gold staining to detect RNA. Peak fractions containing B complexes were pooled, concentrated by centrifugation with an Amicon 50 kD cut-off unit, diluted to decrease the sucrose concentration and reloaded on the same gradients with glutaraldehyde as fixative (Kastner et al., 2008) . The GraFix gradient contained 0%-0.15% of glutaraldehyde and fractions were quenched with 100 mM aspartate immediately after harvesting. For biochemical sample validation, the same procedure was performed but without fixation in the second gradient. The RNA and protein compositions of purified complexes were determined by denaturing PAGE and two-dimensional (2D) gel electrophoresis.
2D gel electrophoresis and mass spectrometry 2D gel electrophoresis of affinity-purified spliceosomal complexes was performed as described previously (Agafonov et al., 2011 ) using a 7.5% acrylamide mono gel in the second dimension for analysis of proteins larger than 50 kDa, or 15% acrylamide for proteins smaller than 50 kDa. For mass spectrometry, Coomassie-stained protein-spots were cut out of the 1D or 2D gels, and proteins were digested in-gel with trypsin and extracted. The extracted peptides were analyzed in a liquid-chromatography coupled electrospray ionization mass spectrometer (LTQ Orbitrap XL) under standard conditions. Proteins were identified by searching fragment spectra against the NCBI non-redundant (nr) database using Mascot as a search engine.
ATP sensitivity of purified B complexes
Affinity-purified B complexes formed on 32 P-labeled MINX-MS2 pre-mRNA were incubated with or without 2mM ATP at 30 C for 30 min. The integrity of the complexes was checked by sedimentation in a 5%-20% (w/v) sucrose gradient containing G-150 buffer followed by Bradford assay of gradient fractions to determine the peak. Aliquots of peak fractions were separated by denaturing 4%-12% NuPAGE (Life Technologies) and RNA was visualized by SYBR Gold staining.
Chase of purified B complexes with nuclear extract Affinity-purified B complexes formed on 32 P-labeled MINX-MS2 pre-mRNA were incubated with splicing buffer alone (20 mM HEPES-KOH pH 7.9, 50 mM NaCl, 3 mM MgCl 2 , 2 mM ATP, 20 mM creatine phosphate) or additionally in the presence of 20% untreated HeLa nuclear extract or extract pre-treated with micrococcal nuclease (NEB) as described previously (Bertram et al., 2017) . The splicing reaction was initiated by addition of 32 P-labeled MINX-MS2 pre-mRNA or purified B complexes, and then incubated at 30 C for 0-90 min. Time point aliquots were analyzed by SDS-PAGE, and the 32 P-labeled RNA was visualized with a Typhoon phosphorimager (GE Healthcare).
Crosslinking of the B complex and crosslink identification After gradient centrifugation, MS2 affinity-purified spliceosomal complexes were crosslinked with 150 mM BS3 for 30 min at 20 C and further purified by a second gradient centrifugation step. Approximately 25 pmol of B complexes were pelleted by ultracentrifugation and analyzed essentially as described before (Bertram et al., 2017) . After digestion with trypsin, peptides were reversephase extracted and fractionated on a Superdex Peptide PC3.2/30 column (GE Healthcare). 50 mL fractions corresponding to an elution volume of 1.2-1.8 ml were analyzed on Thermo Scientific Q Exactive HF, Orbitrap Fusion Tribrid or Orbitrap Fusion Lumos Tribrid mass spectrometers. Protein-protein crosslinks were identified by pLink 1.23 search engine (http://pfind.ict.ac.cn/ software/pLink) and filtered at FDR 1% as recommended by the developer (Yang et al., 2012) . For simplicity, the crosslink score is reported as a negative value of the common logarithm of the original pLink score, i.e., Score = -log 10 (pLink Score). For model building, a maximum distance of 30 Å between the Ca atoms of the crosslinked lysines was allowed.
EM and image processing A negative-stain starting model was built and refined essentially as described previously (Bertram et al., 2017; Singer et al., 2010) . 8,168 cryo-images were recorded at À193 C in a Titan Krios electron microscope (FEI Company, the Netherlands) on a Falcon III direct electron detector at 120,700x magnification resulting in a pixel size of 1.16 Å at the specimen level. 20 frames were recorded for each micrograph with an average dose of 1.5 e À per frame per Å 2 . Motion correction and spatial frequency weighted frame summation was achieved using the MotionCor2 software (Zheng et al., 2017) (http://www.msg.ucsf.edu/em/software/index.html). Summed micrograph images were then evaluated based on real space appearance and CTF parameters and only ca 6,000 with good contrast and isotropic Thon rings were used for particle picking and extraction. Using the particle picking software Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang/) and 40 projections of the negative stain model filtered to 40 Å as a reference, we extracted $550,000 particle images from the pre-sorted, dose-weighted cryo-micrographs and applied several particle sorting steps at the 2D and 3D level. 2D multivariate statistics and classification were first applied to the non-aligned particle images and subsequently to the aligned particles. In each round, only particles comprising better resolved classes were included in further processing. The remaining $407,000 particles were then re-extracted using RELION 2.0 and coarsed 2x in the process. 3D classification of these particles in RELION, featuring ten classes, resulted in $49,000 particles in the overall best defined class. Subsequent rounds of 3D refinement followed by 2D classifications, where particles from the most poorly defined class-sums in RELION were discarded, yielded a 2x coarsed model at 9.9 Å . For the highest resolution structure, the $44,600 remaining particles were re-extracted at their native pixel size using coordinates refined by previous rounds of classification and consequently utilized for an additional round of refinement yielding a 9.3 Å resolution unmasked structure. A soft mask (soft mask 1, Figure S2 ) that included the density harboring Brr2 helicase and the U4 Sm core, with a cut-off of 7 voxel was then used for the refinement and for the determination of resolution. A map with a resolution of 5.4 Å as determined by Fourier shell correlation calculated from two independent datasets with a threshold of 0.143, was obtained. A second soft mask, that excluded the more flexible density region of Brr2 helicase and the U4 Sm core (soft mask 2, Figure S2) was applied during refinement in a similar way as described above and yielded an additional map of this area with a resolution of 4.5 Å as determined by Fourier shell correlation calculated from two independent datasets with a threshold of 0.143. A local resolution plot revealed that there are indeed areas of higher resolution at the RNP core of the B complex that approach 3.5 Å . Some peripheral regions have somewhat lower resolution (Figures 1 and S2) . To obtain the most complete B complex structure at the overall highest possible resolution, sorting schemes were adjusted accordingly. Using a starting model that did not include the head of the B complex during 3D classification, the $407,000 2x coarsed particles (see above) were split into six equally sized groups and 3D classified accordingly, with three classes each. Particles from all classes yielding a (partially) defined structure, regardless of the appearance of the head, were pooled and split again into two subsets of $120,000 particles each. Both particle sets were then again 3D classified into 6 classes each and inspected visually. Particles from the two best defined classes were then pooled and 3D refined without masking in RELION, yielding a model revealing the best achievable head definition at 9.9 Å resolution according to the FSC 0.143 criterion (which we refer to as the unmasked EM density map).
Model fitting and building Available X-ray or homology models of proteins were fit into the EM density using Chimera (Pettersen et al., 2004) . Individual models of substructures (e.g., domains or structural motifs) were further fitted as rigid bodies using Coot (Emsley and Cowtan, 2004) . The models were adjusted manually to fit into the EM density after visual inspection. Disordered regions were removed and regions that were reorganized or were not present in the initial models (e.g., loops and secondary structure elements) were built using Coot. Homology models of proteins were either obtained using the SWISS-MODEL suite (Guex and Peitsch, 1997) , or were directly adapted from the SpliProt3D database (Korneta et al., 2012) . Details of the processing of protein models incorporated into the B structure are described in Table S1 . An initial model of the human U5 snRNA was obtained from the C* complex (PDB: 5MQF, Bertram et al., 2017) and fitted into the 4.5 Å EM density using Coot. MINX pre-mRNA intron bases A56 and G58 could subsequently be modeled as base-pairing with U5 loop 1 bases U41 and U43. This then allowed the placement of all other modeled pre-mRNA bases by tracing in the EM density. U4 snRNA A1-C16 were initially modeled as an idealized double helix base paired with U6 snRNA G59-U74 (helix II) and subsequently refined in Coot. U4 snRNA nucleotides A20-U52 were modeled in a similar manner, based on its crystal structure (PDB: 2OZB, Liu et al., 2007) . Missing U4 bases up to U62 were then modeled in Coot by tracing the EM density. The remaining U4 snRNA bases up to A68 were modeled from its 3 0 terminal helix (which was modeled as an idealized helix) by tracing their path in the EM density. U6 snRNA bases preceding U4/U6 stem II and comprising the helical ACAGA and extended ACAGA box elements, were modeled tracing their path in the EM density using Coot beginning at A30. The U6 5 0 terminal loop and adjacent bases were adapted from the human C* reference structure (PDB: 5MQF, Bertram et al., 2017) . Once the entire coordinate model was built, all proteins were truncated to poly-alanine and a global minimization real space refinement was conducted against the 4.5 Å or 5.4 Å cryo-EM density, respectively, using the real space refine program from the PHENIX suite (Adams et al., 2010) (https://www. phenix-online.org/documentation/reference/real_space_refine.html). The RNA model was validated using the MolProbity server (Davis et al., 2007) and exhibited an all atom clash score of less than 12 and no bad bond-lengths or -angles. The scores for individual RNA nucleotides shown in the final B complex model are provided in a separate HTML file. Final visualization was performed with Chimera and PyMOL (http://www.pymol.org).
DATA AND SOFTWARE AVAILABILITY
The cryo-EM maps have been deposited in the Electron Microscopy Data Bank with accession codes EMDB: 3766 (4.5 Å map), EMDB: 3767 (5.4 Å map), and EMDB: 3769 (unmasked 9.9 Å map). A sharpened version of the unmasked map is deposited under EMDB: 3768. The atomic model has been deposited in the Protein Data Bank under accession code PDB: 5O9Z. separated by denaturing 4%-12% NuPAGE and visualized by SYBR Gold staining. B complexes incubated with ATP not only exhibit the same sedimentation behavior as the control B complexes, but also the same RNA composition, indicating that Brr2 helicase is negatively regulated in the purified B complexes and does not displace U4 from U6 snRNA in the presence of ATP.
Supplemental Figures
(G) Chase of purified B complexes with nuclear extract. Affinity-purified B complexes formed on 32 P-labeled MINX-MS2 pre-mRNA were incubated with untreated HeLa nuclear extract (lanes 1-4) or extract pre-treated with micrococcal nuclease (MN) (lanes 5-8), or with splicing buffer alone (lanes 9-12). The premRNA was efficiently chased into mRNA in the presence of both types of nuclear extract, but not buffer alone, indicating that our purified B complexes are functional and not dead-end complexes. As a control, 32 P-labeled MINX-MS2 pre-mRNA was incubated in the presence of extract pre-treated with MN (lanes 13-15). The pre-mRNA was not spliced with nuclear extract pre-treated with MN, confirming that the vast majority of snRNAs in the MN treated nuclear extract were destroyed. All 2D analyses and in vitro splicing experiments were performed at least twice in two independent experiments. (H) Network of crosslinks between U2 SF3A1 and proteins in the head and the central part of the B complex body. Overview of the positions of selected proteins and RNA in the B complex EM density map (shown is the front view of the B complex; see Figure 1A , left panel), with a schematic diagram showing intermolecular crosslinks between U2 SF3A1 and other indicated proteins, and the likely path of SF3A1. Numbers indicate the positions of crosslinked lysine residues (connected by black lines) in each protein. Numbers in ovals with black borders indicate the residues in the modeled regions of the proteins, whereas those in ovals without borders are residues within non-modeled regions. The latter are arbitrarily placed close (less than 30 Å ) to their crosslinking partners observed in our model. The ovals share the same color as that of the crosslinked protein's name. The crosslinking pattern suggests a path for U2 SF3A1 from the head region along the central axis of the main body close to its foot region, via bridge B3. Closed conformation of Prp8 in the human, catalytically-active C* complex. To achieve this conformation, the RT/En domain must move even closer to the NTD1 domain, generating a large interface between the Prp8 NTD1 and RT/En domains, which now clamps the 5 0 exon instead of the 5 0 ss. In the closed conformation of Prp8, the pocket that accommodates the rearranged catalytic U2/U6 RNA network is generated (see also Bertram et al., 2017) . All complexes are aligned relative to Snu114 and the Prp8 NTD1 domain. Prp8 also adopts a very similar closed conformation in the S. cerevisiae B act , C, and C* complexes, as well as in the S. pombe intron-lariat spliceosome (Fica et al., 2017; Galej et al., 2016; Hang et al., 2015; Rauhut et al., 2016; Wan et al., 2016a; Yan et al., 2016 Yan et al., , 2017 . Overview of the structure and organization of proteins in the purified S. cerevisiae tri-snRNP as reported by Wan et al. (2016b) (left) or Nguyen et al. (2016) (right) , and in the human spliceosomal B complex (middle) as determined by cryo-EM. All complexes are aligned relative to Snu114 and the Prp8 NTD1 domain. The coloring of proteins (labeled in the middle panel) is conserved in all three panels. The structural organization of Prp8, Brr2, Prp6 and the U4/U6 proteins in the yeast tri-snRNP is highly similar to their organization in the human B complex, consistent with the idea that the purified yeast tri-snRNPs are either activated at an early stage, i.e., before they join the spliceosome to form the B complex, or that they might potentially be derived by dissociation of spliceosomal B complexes. In addition, unlike human tri-snRNPs, purified yeast tri-snRNPs contain Prp38 and Snu23, but lack Prp28. Interestingly, one of the cryo-EM structures of a yeast trisnRNP exhibits density elements, into which the yeast Prp38 NTD in complex with a helices of Snu23 and Spp381 (the yeast likely homolog of MFAP1) would fit nicely. While this density was tentatively assigned to helical regions of yeast Snu66 by Nguyen et al. (2016) , they more likely contain the yeast Prp38 complex, as they are located at the equivalent positon as the hPrp38 complex in the human B complex and can be even superimposed. Indeed, in the recently published yeast B complex structure (Plaschka et al., 2017) , this density was shown to comprise the yeast Prp38/Snu23/Spp381 protein complex.
